The latest information about the novel coronavirus identified in Wuhan, China, and advice on how pharmacists can help concerned patients and the public.
The under-representation of women in clinical trials is slowly being addressed, but we cannot move towards truly personalised healthcare unless we have an equal balance of the sexes in all new medicine trials.
Community pharmacy is providing a vital connection to support older and clinically vulnerable patients during lockdown in the UK.
The temporary field hospitals set up across the UK to help the NHS cope during the COVID-19 pandemic have given hospital pharmacists a unique opportunity for valuable learning and teamwork.
There has been a surge in demand for gender identity services in the UK over the past five years. Although the current role of pharmacists is limited, their potential contribution within a multidisciplinary team supporting transgender patients is beginning to emerge.
When Public Health England published new guidance on the use of personal protective equipment during the COVID-19 pandemic on 2 April 2020, pharmacy’s representative bodies thought the battle was won.
As researchers around the globe drop everything to find a treatment for COVID-19, we look at the likely frontrunners for managing this deadly disease.
Incidence of sexually transmitted infections is increasing and antimicrobial resistance is adding fuel to the fire, particularly in the case of gonorrhoea. In response, researchers are working on three major strategies to help reduce its spread and maintain susceptibility to antibiotics.
Going against type: the new class of cancer therapies targeting mutations rather than tissuesSubscription
‘Tumour agnostic’ drugs offer a more effective and tolerable therapy for a wide range of people with cancer, so why has the NHS rejected its first one?
More than 18 months of hormone replacement therapy product shortages have had a drastic impact on the lives of people who rely on them, but nobody seems to know why they are happening.
The number of social prescribing staff has more than doubled in the past year, but pharmacy has yet to engage with schemes that can help patients with their wellbeing.
While medicines can be an important part of dementia treatment, there are doubts over whether they provide meaningful benefits for patients. As a result, emphasis is being placed on non-pharmacological approaches, some of which have had a transformative impact on the lives of patients with dementia.
Delays in accessing pain services in some parts of the country mean that people with chronic pain are struggling to cope.
The deadly online prescribing loopholeSubscription
Online prescribing has long operated in a regulatory grey area, with some online pharmacies evading oversight by exploiting technical loopholes in the law.
Failing the frailestSubscription
A new analysis suggests that thousands of vulnerable older people could be at risk because their medicines have not been reviewed by their GP.
A cloud of doubt over the sunshine vitaminSubscription
Negative results in trials of vitamin D supplementation have led researchers to question the best way of reaching those who are deficient.
A closer look at the progress made so far on NHS England’s new national genomic medicine service.
Are universities failing pharmacy trainees?Subscription
Graduates from some pharmacy schools achieve significantly higher final assessment pass rates than others.
A new class of sleep medicines, could provide relief for people living with insomnia, but pharmaceutical companies are struggling to bring them to the market.
Despite the rise of resistant infections, national figures show that antibiotic use continues to grow in hospitals. However, some trusts in England are stepping up their stewardship efforts and achieving significant reductions. Here, three trusts share the secrets to their success.
A closer look at the progress made so far on introducing a nationwide foundation training scheme.
‘Urgent action’ needed on pharmacist shortagesSubscription
NHS workforce planners warn that they are running out of pharmacists as demand for the profession rises.
With almost 1,400 reports of controlled drugs being lost, stolen or missing in 2018/2019, there are concerns regarding the increasing sophistication of those trying to subvert the system.
One year since UK law changed to enable medical cannabis to be prescribed, researchers are exploring the drug’s potential for treating post-traumatic stress disorder, schizophrenia and attention deficit hyperactivity disorder.
As the prevalence of sexually transmitted infections continues to rise and sexual health services remain under financial strain, pharmacists are increasingly being called upon to do more to bridge the gap.
The government’s latest scheme to tackle thinly stretched NHS services is set to launch on 29 October 2019, and it places community pharmacy at its core.
Communication between hospital and community pharmacists when patients are discharged is often absent, which can have a detrimental impact on patients’ health. The transfers of care around medicines — or ‘TCAM’ — scheme is beginning to change this, but there are several obstacles to overcome.
Not all pharmacists are convinced by the government’s claims that it is ready to leave the EU without a deal in place.
Power of one: what is holding polypills back?Subscription
Single pills with fixed-dose combinations of several medicines are not commonplace for the treatment of cardiovascular disease. As the first randomised controlled trial to show a polypill can cut the risk of heart attacks is published, we look at why, nearly two decades after it was first proposed, development and uptake is limited.
Binning the sharps: the quest for oral insulinSubscription
The pharmaceutical industry has been trying to develop oral formulations of insulin since the 1920s without success, but, over the past few years, several new oral delivery systems have shown promise in clinical trials.